GlassScriptPhysician profile
George Rofaiel
NPI 1265622138
$1,888.04
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $96.27 · 2022: $1,331 · 2023: $144 · 2024: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.24 |
| Education | $130.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,326.76 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $127.84 | 2023-2024 | Prevymis |
| Takeda Pharmaceuticals U.S.A., INC. | $124.74 | 2024 | Livtencity |
| Sanofi-Aventis U.S. LLC | $100.04 | 2022 | |
| Medtronic, INC. | $85.33 | 2024 | Signia |
| Veloxis Pharmaceuticals, INC. | $81.74 | 2023 | Envarsus |
| Abbvie INC. | $22.86 | 2023 | Botox |
| Dynavax Technologies Corporation | $18.73 | 2023 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Rofaiel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.